Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2007
12/27/2007CA2655986A1 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
12/27/2007CA2655933A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007CA2655759A1 Compositions and kits comprising a melatonin component and a chondroprotective component
12/27/2007CA2655331A1 Lactoferrin as a radioprotective agent
12/27/2007CA2655067A1 Process for the production of bromelain by means of substances that induce proteins in pineapple plants established in vitro
12/27/2007CA2655036A1 Methods and compositions for treating ophthalmic conditions via modulation of megalin activity
12/27/2007CA2655022A1 Use cathelicidin antimicrobial protein (hcap18 ) as anticancer agent
12/27/2007CA2654884A1 Macrocyclic compounds as antiviral agents
12/27/2007CA2654510A1 Vegf antagonist formulations suitable for intravitreal administration
12/27/2007CA2653061A1 Stabilized proteins
12/27/2007CA2652924A1 Methods of modulating il-22 and il-17
12/27/2007CA2637036A1 Water stabilized aerosol formulation system and method of making
12/26/2007EP1870467A1 Polypeptide hormone Phosphatonin
12/26/2007EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer
12/26/2007EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies
12/26/2007EP1870464A2 Methods and compositions for inhibiting neoplastic cell growth
12/26/2007EP1870461A2 Method for identifying within a mammal a DNA encoding physiologically active polypeptide
12/26/2007EP1870453A1 Novel protease, microorganism producing the same, and application thereof
12/26/2007EP1870420A1 Peptides regulating the surface expression of the T cell receptor
12/26/2007EP1870419A2 Modulators of beta-amyloid peptide aggregation comprising d-amino acids
12/26/2007EP1870115A1 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
12/26/2007EP1870110A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen
12/26/2007EP1870108A1 Antitumor agent and novel dnase
12/26/2007EP1870107A1 Use of inducer of promyelocytic leukemia protein (PML) for treating polyglutamine expansion neurodegenerative diseases
12/26/2007EP1870106A2 Combination of egf/ghrp-6 for neuroregeneration of central nervous system
12/26/2007EP1870089A1 A gynecological pharmaceutics-containing microspherical vascular suppository of sodium alginate and its preparation method
12/26/2007EP1869464A2 Rage/diaphanous interaction and related compositions and methods
12/26/2007EP1869206A2 Enzyme sensors including environmentally sensitive or fluorescent labels and uses thereof
12/26/2007EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer
12/26/2007EP1869181A2 Influenza therapeutic
12/26/2007EP1869081A2 POP2 NFkB-INHIBITING POLYPEPTIDES, NUCLEIC ACIDS AND METHODS OF USE
12/26/2007EP1869077A2 Q3 sparc deletion mutant and uses thereof
12/26/2007EP1869071A2 Tnf-alpha binding polypeptide, uses thereof and methods employing it
12/26/2007EP1869069A2 Means and methods for producing polymers comprising peptide in a side chain
12/26/2007EP1869068A1 Antibacterial amide-macrocycles v
12/26/2007EP1868644A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy
12/26/2007EP1868638A2 Cross-beta structure on microbial organisms
12/26/2007EP1868637A1 Mechano growth factor peptides and their use
12/26/2007EP1868636A2 Uses of recombinant super-compound interferons
12/26/2007EP1868635A1 Methods for treating immune disorders associated with graft transplantation with soluble ctla4 mutant molecules
12/26/2007EP1868634A2 Compositions and methods for inhibiting g protein signaling
12/26/2007EP1868632A2 Dermatological and/or cosmetic composition containing proteins of the sirt family
12/26/2007EP1868631A1 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
12/26/2007EP1868630A2 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
12/26/2007EP1868629A1 Therapeutic peptides for the treatment of metastatic cancer
12/26/2007EP1868628A2 Compounds, compositions and methods for the treatment of poxvirus infections
12/26/2007EP1868627A2 Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
12/26/2007EP1868572A2 Administration of glutathione (reduced) via intravenous or encapsulated in liposome for treatment of tnf-alpha effects and elu-like viral symptoms
12/26/2007EP1722819B1 Method for solubilising peptide mixtures
12/26/2007EP1691744A4 Methods and reagents for the treatment of inflammatory disorders
12/26/2007EP1680121A4 Methods and reagents for the treatment of immunoinflammatory disorders
12/26/2007EP1654036B1 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
12/26/2007EP1615663B1 Agent for treating leishmania infections
12/26/2007EP1592437A4 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
12/26/2007EP1565203A4 Templated native silk smectic gels
12/26/2007EP1412384B1 Stable formulation of modified glp-1
12/26/2007EP1409518B1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
12/26/2007EP1401869B1 Molecules and methods for inhibiting shedding of kim-1
12/26/2007EP1345620B1 Stable enzymatic wound debrider
12/26/2007EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/26/2007EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/26/2007EP1235596B1 Use of lytic toxins and toxin conjugates
12/26/2007EP1187634B1 Cell growth inhibition
12/26/2007EP1056778B1 G protein-coupled receptor antagonists
12/26/2007EP0996710B1 Component of bromelain
12/26/2007EP0973895B1 Transcription factor islet-brain 1 (ib1)
12/26/2007EP0877812B1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor
12/26/2007EP0862455B1 Interferon-polymer conjugates and process for preparing the same
12/26/2007EP0837630B1 Prodrugs of pharmaceuticals with improved bioavailability
12/26/2007EP0778848B1 Agents for inducing apoptosis and applications of said agents in therapy
12/26/2007EP0517829B2 Improved chimeric toxins
12/26/2007CN101094866A G protein coupled receptor agonists and antagonists and methods of use
12/26/2007CN101094863A Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
12/26/2007CN101094847A Aryloxy-substituted benzimidazole derivatives
12/26/2007CN101094833A Tetrapeptide analogs
12/26/2007CN101094692A Improved quenching methods for red blood cell inactivation process
12/26/2007CN101094689A Treatment of obesity and related disorders
12/26/2007CN101094685A Use of flagellin in the immunotherapy of yersinia pestis
12/26/2007CN101094684A Chemokine combinations to mobilize progenitor/stem cells
12/26/2007CN101094673A Combination comprising zd6474 and an antiandrogen
12/26/2007CN101092616A Expressing and purifying neutrophilic granule protein NGP
12/26/2007CN101092612A New thrombin with hemostaitic activityin in category of snake poison of hundred-paced pit
12/26/2007CN101092455A Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/26/2007CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents
12/26/2007CN101092452A Preparation method for both of micromolecule polypeptide of tumor chalone for anti angiogenesis, and fusion protein
12/26/2007CN101092450A Heparinase polypeptide epitope combined to molecules in human MIIC ¿CI category
12/26/2007CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007CN101091793A New usage of anti alcoholic drug containing acetadehyde dehydrogenase
12/26/2007CN101091792A Multi-dose erythropoietin formulations
12/26/2007CN101091791A Injection of brain peptide, and preparation method
12/26/2007CN101091790A Oral taking brain peptide, and preparation method
12/26/2007CN101091789A Application of ocean collagen peptide in preparing medicine or foodstuff for adjusting immunity
12/26/2007CN101091722A Injection of hydrolyzed peptide of liver
12/26/2007CN101091697A Aerosol of brain peptide and preparation method
12/26/2007CN100357436C SiRNA for inhibiting Stat3 gene expression and preparation thereof
12/26/2007CN100357433C eNOS mutations useful for gene therapy and therapeutic screening
12/26/2007CN100357430C 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity
12/26/2007CN100357324C Effectors of innate immunity
12/26/2007CN100357323C Cell shifting related protein and its coding gene and application
12/26/2007CN100357322C Disintegrating element for poisonous snake and its coding gene and use
1 ... 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 ... 3163